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Abstract 
Machine learning algorithms have attained widespread use in assessing the potential 
toxicities of pharmaceuticals and industrial chemicals because of their faster-speed and lower-
cost compared to experimental bioassays. Gradient boosting is an effective algorithm that often 
achieves high predictivity, but historically the relative long computational time limited its 
applications in predicting large compound libraries or developing in silico predictive models 
that require frequent retraining. LightGBM, a recent improvement of the gradient boosting 
algorithm inherited its high predictivity but resolved its scalability and long computational time 
by adopting leaf-wise tree growth strategy and introducing novel techniques. In this study, we 
compared the predictive performance and the computational time of LightGBM to deep neural 
networks, random forests, support vector machines, and XGBoost. All algorithms were 
rigorously evaluated on publicly available Tox21 and mutagenicity datasets using a Bayesian 
optimization integrated nested 10-fold cross-validation scheme that performs hyperparameter 
optimization while examining model generalizability and transferability to new data. The 
evaluation results demonstrated that LightGBM is an effective and highly scalable algorithm 
offering the best predictive performance while consuming significantly shorter computational 
time than the other investigated algorithms across all Tox21 and mutagenicity datasets. We 
recommend LightGBM for applications in in silico safety assessment and also in other areas 
of cheminformatics to fulfill the ever-growing demand for accurate and rapid prediction of 
various toxicity or activity related endpoints of large compound libraries present in the 






Early prediction of compound toxicity accelerates drug discovery and reduces the safety-
related attritions during drug development.1 One of the predominant approaches for such 
predictions is machine learning (ML). In this setting, ML uses statistical algorithms to 
summarize the historic experimental data and predict potential toxicities for the new 
compounds, as illustrated by examples published in recent literature.2 Remarkably, in some 
applications, ML even outperforms animal tests.3 
For toxicity predictions, as with all ML applications, the operator has to make a decision on 
which algorithm to deploy. Many different ML techniques have been employed successfully 
for the prediction of toxicity and there is currently no technique clearly outperforming the 
others.4 This is in part due to the high number of different scenarios that can be encountered in 
toxicity predictions, from small focused datasets to “big data” collected from diverse sources 
and from specific molecular interactions to organism level toxicities. It is therefore necessary 
that the computational scientists’ toolbox is diverse and emerging methods can be valuable 
additions to this. 
Gradient boosting5 (GB) is a powerful ML algorithm that has seen multiple uses for toxicity 
predictions.6,7 Although capable of generating highly predictive models, the main limitations 
with GB are the unsatisfactory long training time and scalability.8 This challenges its 
application to ever-growing compound datasets with high feature dimensions or its deployment 
in the drug discovery environment requiring regular retraining of the models. 
LightGBM,8 a recent modified GB algorithm, tackles these limitations by adopting a leaf-
wise tree growth strategy and introducing novel techniques, e.g. gradient-based one-side 
sampling and exclusive feature bundling. This approach results in a faster and less resource 
intensive implementation of GB suitable for frequent retraining and rapid assessment of larger 
high-dimensional datasets. LightGBM has been demonstrated to be up to 20 times faster to 
train on the same data,8 compared to the XGBoost9 implementation of GB. The algorithm has 
been implemented successfully on issuing peer-to-peer loan in FinTech industry10 and on 
forecasting wind power production in smart grid industry11. 
ML model evaluation and selection strategies for cheminformatics applications require the 
judicial use of both validation and test data, which has been highlighted previously by Tropsha 
et al.12 Not only is it important to establish the accuracy of a new algorithm, but also its 
robustness, transferability, and ease of deployment are important parameters to evaluate. This 
is a key aspect as methods are often chosen based on their performance on one set and then 
expected to deliver the same level of performance when applied to new data. Furthermore, 
factors like the random partitioning of data might influence the results, something that can be 
counteracted by training multiple models on the same data but using different train and test 
splits. Nested cross validation strategies have been proposed to provide more robust and 
generalized evaluation of the model performance.13 The inner cross validation is used to train 
the model and tune the model hyperparameter parameters, while the outer cross validation is 
used to evaluate general performance of the model selected by the inner cross validation. 
Bayesian optimization is an efficient method for global optimization of the ML algorithm 
hyperparameters as the method converges faster and requires fewer iterations for 
hyperparameter tuning than both grid search and random search.14 
The Tox21 and mutagenicity datasets are two compound datasets commonly used for in silico 
toxicity model development and comparison.15–18 The Tox21 datasets19 include the in vitro 
toxicity screening results of approximately 10,000 compounds against a total of 12 Nuclear 
Receptor (NR) and Stress Response (SR) targets. The mutagenicity dataset published by 
Hansen et al.20 contains screening results of approximately 6,500 compounds in the Ames 
bacteria mutagenicity test that measures if the tested compounds cause mutations in the DNA 
of the test microbial organism. 
In this study, we evaluate the performance of LightGBM algorithm on classification of 
compound toxicity against a collection of toxicologically relevant endpoints based on the 
Tox21 and mutagenicity datasets. We compare its predictive performance and the computation 
time to that of the closely related gradient boosting algorithm XGBoost and three other well-
established ML algorithms, deep feedforward neural network (DNN), random forest (RF), and 
support vector machine classifier (SVC). We also discuss the advantages of Bayesian 
optimization integrated nested cross validations in proper validation of new ML methods. 
 
Materials and Methods 
Computation. The computations were performed in Python v2.7.12 using one 28-thread 
Intel Xeon E5-2690v4 CPU on a Linux server with 128Gb memory. The following Python 
packages were installed for the calculations: Keras v1.2.121, LightGBM v2.1.08, Scikit-learn 
v0.18.122, Scikit-optimize v0.423, Tensorflow v0.12.124, and XGBoost v0.8.09. 
Compound Datasets and Features. We downloaded the compounds of the Tox 2125 and 
mutagenicity datasets20 along with their associated activities for toxicological endpoints. The 
number of active and inactive compounds in each dataset and the descriptions of the assay 
targets are shown in Table 1. The compound structures were standardized using the IMI eTOX 
project standardizer26 in combination with tautomer standardization using the MolVS 
standardizer27. RDKit28 molecular descriptors and Morgan fingerprints were calculated for all 
compounds. These two feature sets are referred to in this study as “molecular descriptors” and 
“fingerprints” respectively. The molecular descriptor set consists of 97 features describing the 
structural and physicochemical properties of the compounds, e.g. the number of rings, 
topological polar surface area, and lipophilicity. The Morgan fingerprint is a reimplementation 
of the extended-connectivity fingerprint (ECFP)29. The method generated the fingerprints by 
parsing each compound atom and obtain all possible paths through this atom with a predefined 
radius. Each unique path is hashed to predefined maximum number of bits. Here we set 
radius=4 when generating the fingerprints and hashed them to 1024 bits. The same structure 
preparation, descriptors/fingerprints generation, and feature/class preparation protocol have 
been used for classification problems with good performance in previous studies.30,31 
Table 1. Number of active and inactive compounds in each the Tox21 and mutagenicity 
datasets and the target and assay information. 
Dataset Target/Assay Number of active 
compounds 
Number of inactive 
compounds 
Tox21 Datasets    
nr-ahr Aryl hydrocarbon 
receptor 
942 7,103 
nr-ar Androgen Receptor 376 8,843 
nr-ar-lbd Androgen receptor 
(luciferase assay) 
302 8,174 
nr-aromatase Aromatase 346 6,759 
nr-er Estrogen receptor 927 6,665 








sr-are Nuclear factor 
(erythroid-derived 




indicated by ATAD5 
334 8,628 






sr-p53 DNA damage p53-
pathway 
528 7,981 
Mutagenicity Data    
Hansen et al Ames test 
(mutagenicity) 
3,502 3,007 
The molecular descriptors were scaled using the scikit-learn MinMaxScaler to a range 
between 0 and 1. The datasets were divided into active and inactive and this investigation was 
accordingly formulated as a binary classification problem. Tox21 datasets are imbalanced with 
regards to active and inactive compound classes. Class weights of each dataset were calculated 
under the ‘balanced’ setting using the scikit-learn package and applied to penalize the ML 
algorithms for misclassification of the minority class to achieve balanced prediction results. 
Machine learning algorithms and modeling scheme. Classification models based on 
Tox21 and mutagenicity datasets were developed using LightGBM and four regularly used 
algorithms, namely DNN, SVC, RF, and XGBoost. The models were optimized and 
extensively evaluated with the following modeling scheme illustrated in Figure 1. 
 
Figure 1. Schematic illustrating how the inner and outer cross validation loops were used to 
tune the model parameters and perform the predictions on the validation and test data.  
The modeling scheme was designed to integrate nested cross validation and Bayesian 
optimization strategies because of the following reasons: 1) nested cross validation reduces 
bias in model performance evaluation and provides a more robust mean for assessing the model 
transferability on ‘unseen’ data, comparing to naïve cross validation;32 2) Bayesian 
optimization has been suggested as a recommended method for hyperparameter tuning, as it 
achieves better performance on the test set while requiring fewer iterations than grid search 
and random search.33 
Each dataset was split into inner and outer sets using a nested 10-fold cross validation split 
setting in the scheme. Inner cross validation sets were used to train the models based on the 
selected ML algorithms, decide the best set of hyperparameters achieving highest balanced 
accuracy for the models and to perform initial evaluation of model performance (referred as 
‘validation results’). Hyperparameter selection was performed using 100 iterations of Bayesian 
optimization with Gaussian processes as surrogate model and expected improvement as 
acquisition function from the scikit-optimize package. The generalization performance and 
transferability of the models were further evaluated on the outer cross validation sets (referred 
as ‘test results’). 
LightGBM 
LightGBM is a recent modification of the GB algorithm. It improves the efficiency and 
scalability of the algorithm without sacrificing its inherited effective performance. Seven 
hyperparameters governing the performance of the LightGBM classifier were optimized within 
the following predefined ranges suggested by the package manual: number of leaves 
(‘num_leaves’, 30-500), number of feature bins (‘max_bin’, 250-500), number of iterations 
(‘n_estimators’, 50-900), number of samples in one leaf (‘min_child_samples’, 30-500), model 
depth (‘max_depth’, 5-12), learning rate (‘learning_rate’, 10-6-10-1), and fraction of data used 
for training (‘bagging_fraction’, 0.8). 
XGBoost 
XGBoost is another variant of the GB algorithm. It was designed to be highly scalable by 
adopting a sparsity-aware algorithm for sparse data and weighted quantile sketch for 
approximate tree learning.9 We implemented the XGBoost classifier with the fast histogram 
optimized approximate greedy algorithm (tree_method=hist) and optimized the following 
hyperparameters to achieve a fair comparison between the XGBoost and LightGBM 
algorithms; number of iterations ('n_estimators', 50-900), model depth (‘max_depth’, 5-12), 
and learning rate (‘learning_rate’, 10-6-10-1). 
Deep Neural Networks 
Deep feedforward neural network has been identified as the ‘most effective’ classification 
algorithm during Merck Kaggle contest34 and Tox21 challenge15. We implemented a three-
hidden-layer DNN classification model using Keras with the Tensorflow backend. The model 
hyperparameters were optimized within the predefined range applied in Korotcov et al.35: 
number of hidden units (200-2,000), epoch (20-100), learning rate (10-4-10-2), size of mini 
batch size (128), initial weight (random normal), optimization algorithm (Adam), activation 
function (relu for hidden layers; softmax for output layer), dropout rates for hidden layers (layer 
1: 0.25, layer 2: 0.25, layer 3: 0.1). 
Support Vector Machine Classifier 
SVC performs classification by defining an optimal hyperplane that maximizes the margin 
between classes.36,37 Non-linear classification is achieved by transforming the data into a higher 
dimensional feature space using non-linear kernel function (‘kernel trick’) and then performing 
linear separation. LibSVM with radial basis function kernel from scikit-learn was used to 
develop the classification models with hyperparameters optimized within the predefined ranges 
suggested by Alvarsson et al.16: gamma (10-5-10), and C value:(1-1200). 
  Random Forest  
RF is an ensemble algorithm bagging the results of decision tree classifiers built on subsets of 
the data.38 RF models (number of trees: 100-1,000) were developed as baseline models to be 
compared with the corresponding models derived by the algorithms mentioned before. 
The list of optimized hyperparameters for each ML algorithm and their value ranges are 
provided in Table S1. 
Performance evaluation. The performance of the investigated algorithms was evaluated 
based on their balanced accuracy (BA), Cohen's kappa (Kappa), Matthews correlation 
coefficient (MCC), positive predictive value (PPV), negative predictive value (NPV), ROC- 
area under curve (AUC), sensitivity (SE) and specificity (SP) values. The equations of these 
performance metrics are given in the supporting information. Balanced accuracy was chosen 
as the scoring function for the Bayesian optimization algorithm since it provides good 
estimation of the model performance on imbalanced datasets.39 The computation time of the 
investigated ML algorithms was also recorded to indicate the speed of each method. 
Statistical hypothesis testing using Bonferroni correction was performed in order to compare 
the differences among algorithms and select the best performing one with the highest balanced 
accuracy values. The compute times were compared using Wilcoxon Signed-Rank Test 
corrected for multiple testing using Bonferroni correction (significance level = 0.05). 
The percentage of compounds in the test sets outside the model applicability domain was 
assessed by performing random projection (known for preserving inter-object distances) with 
a 10-fold reduction in dimensionality for the all datasets. 
Results and Discussions 
The thirteen Tox21 and mutagenicity datasets were described using both molecular 
descriptors and fingerprints, resulting in a total of 26 different datasets for each ML algorithm. 
The model performance was evaluated using subsets from inner 10-fold CV (validation sets) 
and outer 10-fold CV (test sets). The balanced accuracy values obtained for the 26 different 
datasets using the five ML algorithms varied between about 0.6 and 0.876 (Table S2). The 
balanced accuracy values of models developed in this study are comparable to the previous 
Tox21 Challenge winning model results that reported a span of balanced accuracy between 
0.68 to 0.9 for the datasets. Although, the evaluation used a specific leaderboard set not used 
in this study. The general trend shown in Figures 2, 3 and Table 2 is that LightGBM gave the 
best prediction for the Tox21 and mutagenicity datasets followed by XGBoost, SVC, DNN, 
and RF algorithms, when comparing their averaged evaluation metric values on the validation 
and test sets. We also examined the balance between sensitivity (SE) and specificity (SP) in 
the prediction of validation and test sets (Figure S1). Table 3 shows the number of instances 
each algorithm significantly outperformed the others (see Table S5 for p-values). The statistical 
testing demonstrated that LightGBM had significantly better performance on balanced 
accuracy than the other four algorithms in the majority of datasets. 
 
Figure 2. Balanced accuracy values of the five algorithms across validation and test subsets of 
the Tox21 and mutagenicity datasets described using RDKit molecular descriptors. 
 
Figure 3. Balanced accuracy values of the five algorithms across validation and test subsets of 
the Tox21 and mutagenicity datasets described using Morgan fingerprints.  
Table 2. Averaged values of area under curve (AUC), balanced accuracy (BA), Cohen's kappa 
(Kappa), Matthews correlation coefficient (MCC), sensitivity (SE) and specificity (SP) for the 
five ML algorithms on the validation (V) and test subsets (T) of the Tox21 and mutagenicity 
datasets described with RDKit molecular descriptors (MD) and Morgan fingerprints (FP). 
  LightGBM RF SVC XGB DNN 
Metrics Features V T V T V T V T V T 
AUC 
FP 0.836 0.786 a 0.859 0.723 0.805 0.762 0.835 0.768 0.733 0.736 
MD 0.855 0.800 0.865 0.728 0.836 0.795 0.857 0.784 0.682 0.694 
BA 
FP 0.775 0.786 0.698 0.723 0.747 0.762 0.754 0.768 0.733 0.736 
MD 0.784 0.800 0.701 0.728 0.781 0.795 0.763 0.784 0.682 0.694 
Kappa 
 
FP 0.415 0.424 0.480 0.531 0.367 0.368 0.504 0.534 0.522 0.532 
MD 0.433 0.440 0.484 0.538 0.393 0.402 0.494 0.524 0.430 0.463 
MCC 
FP 0.442 0.448 0.513 0.556 0.394 0.396 0.519 0.541 0.534 0.544 
MD 0.461 0.467 0.516 0.561 0.428 0.436 0.511 0.532 0.461 0.491 
SE 
FP 0.657 0.672 0.424 0.474 0.618 0.642 0.572 0.595 0.508 0.512 
MD 0.674 0.700 0.430 0.484 0.689 0.708 0.598 0.636 0.398 0.421 
SP 
FP 0.892 0.900 0.972 0.972 0.876 0.881 0.936 0.941 0.958 0.960 
MD 0.893 0.900 0.973 0.973 0.873 0.882 0.927 0.932 0.966 0.968 
a. The highest value in each metric for the validation and test sets were highlighted in bold. 
Table 3. Statistical comparison results on the balanced accuracy values of the five ML 
algorithms on the test subsets of the Tox21 and mutagenicity datasets. The performance of each 
algorithm was compared to that of the other algorithm across the 13 datasets described with 








LightGBM 76 79 104 
SVC 60 87 104 
XGB 34 61 104 
DNN 1 59 104 
RF 3 62 104 
 
We also observed that certain Tox21 datasets (e.g. nr-er and sr-hse sets) were more 
challenging to predict. The LightGBM algorithm outperformed the other algorithms also in 
prediction of these challenging datasets. For all the ML algorithms in this study, the models 
built using molecular descriptors resulted in higher balanced accuracies compared to the 
corresponding models based on fingerprints (Figure 4). 
 
Figure 4. Average values of area under curve (AUC), balanced accuracy (BA), Cohen's 
kappa (Kappa), Matthews correlation coefficient (MCC), sensitivity (SE) and 
Specificity (SP) for the five algorithms on the validation and test subsets of the Tox21 
and mutagenicity datasets described using RDKit molecular descriptors (MD) and 
Morgan fingerprints (FP), respectively. 
 
In addition to the predictive performance, we also compared the total computational time 
consumed by the five algorithms on tuning their hyperparameters using Bayesian optimization 
and performing model evaluations using nested cross-validation (Figure 5). All differences 
between the algorithms with respect to compute times are statistically significant (significance 
level = 0.05) over the 13 endpoints except for RF versus XGBoost (fingerprints) and 
LightGBM versus SVC (molecular descriptors). 
 
Figure 5. Computational time for the five algorithms across the Tox21 and mutagenicity 
datasets using molecular descriptors and fingerprints, respectively. 
LightGBM was the fastest algorithm among the investigated algorithms as it consumed the 
shortest computation time for all datasets in this study (Table S3), whereas DNN was the most 
time-consuming algorithm, requiring, on average, approximately 37 times longer 
computational time than LightGBM due to large number of algorithm parameters (Table 4). 
We also observed that the investigated algorithms required more computational time to model 
higher dimensional fingerprints compared to molecular descriptors. Interestingly, gradient 
boosting algorithms, i.e. LightGBM and XGBoost, showed highly scalable characteristics, as 
they required similar amount of computation time in developing models using molecular 
descriptors and fingerprints. This is contrasted by the other three investigated algorithms, as 
exemplified by SVC that required up to approximately nine times longer computational time 
to model fingerprint compared to molecular descriptor (Table 4 and Figure 5). 
Table 4. The average computation time for the five ML algorithms on the Bayesian 
optimization integrated nested cross validation scheme of the Tox21 and mutagenicity datasets 
described with RDKit molecular descriptors and Morgan fingerprints. 
 
 Average computation time (mins) 
Feature type LightGBM RF SVC XGB DNN 
Molecular descriptors 121 199 118 339 4,790 
Fingerprints 144 476 1,047 354 5,096 
 
Although recent trends in cheminformatics have seen a rise in more computationally 
intensive approaches by using different varieties of deep neural networks that have 
demonstrated their values in the area of image recognition, SMILES based sequence modeling, 
multi-tasking, and generative models,40 there is still a need for algorithms that are fast to train 
and easy to deploy while delivering high and robust predictive performance in the classical 
CPU computation environment. In this study we have shown through a thorough evaluation 
procedure that LightGBM fulfills these criteria and reliably outperformed the DNN algorithm 
in terms of both balanced accuracy as well as computation time, which emphasizes LightGBM 
as a suitable option for rapid in silico assessment of the toxicity of ever-growing number of 
industrial or pharmaceutical compounds.41,42 While we have applied LightGBM to predictions 
of toxicity data we expect this to be representative of the performance across many areas of 
cheminformatics as well. 
The percentage of test compounds outside the model applicability domain was assessed by 
performing random projection with a 10-fold reduction in dimensionality for the datasets. 
According to the assessment results (Table S6), the maximum percentage of test compounds 
outside the applicability domain is 3.7 % using the mean minimum distance to the closest 
neighbor for the test folds of the inner validation loop + 2*std (within 95 % confidence interval) 
of these minimum distances as cut-off when comparing to the minimum distance of the outer 
test compounds. 
The performance and speed of the LightGBM algorithm are mainly determined by the 
following six hyperparameters (given in Table S1) and the interquartile ranges and medians of 
suggested hyperparameter settings are provided in Table 5 and the exact values are shown in 
Table S4. 
1; the number of leaves in the classification tree controls the model complexity. Larger values 
could improve model accuracy but may lead to overfitting. The LightGBM models developed 
using either molecular descriptors or fingerprints adopted similar median values for the number 
of leaves ranging between 140 and 250 (except for nr-er-lbd set) that could improve model 
accuracy and also avoid overfitting.  
2; learning rate regulates the step size on the weights with respect to the loss gradient. The 
LightGBM models developed using the two feature types adopted comparable learning rates 
in the range of 0.004 to 0.042 to that could avoid local minima but reduce convergence time.  
3; model depth limits the complexity and prevents overfitting. A majority (18 out of 26) of 
the models were developed with depth smaller than 10.  The models (11 out of 13) developed 
with molecular descriptors are more likely to choose smaller values (median = 7) of the 
‘max_depth’ compared to models developed with fingerprints (median = 10), which might be 
related to their higher dimensionality.  
4; The LightGBM models in this study tend to require a significant number of iterations 
(approximate median = 570) to improve balanced accuracy. However, the computation times 
still remained short due to the leaf-wise growth structure and good parallel computational 
performance of this algorithm.  
5; Larger number of samples in one leaf prevent model overfitting. LightGBM models 
developed based on descriptors resulted in more samples (median = 298) in each leaf than the 
corresponding fingerprint based models (median = 55), which might be due to molecular 
descriptors having continuous values whereas fingerprints are represented as binary.  
6; LightGBM models used comparable number of feature bin values for both descriptor and 
fingerprint datasets, which could explain its similar computational time between the two feature 
types. 
Table 5. The interquartile ranges and medians of suggested hyperparameter settings for 
LightGBM models developed based on Tox21 and mutagenicity datasets described with RDKit 
molecular descriptors and Morgan fingerprints by the Bayesian optimization integrated nested 
cross validation scheme. 







'num_leaves' number of leaves 159-231 (190) 151-248 (212) 
'learning_rate' learning rate 0.009-0.02 (0.016) 0.01-0.02 (0.013) 
'max_depth' max model depth 7-8 (7) 8-11 (10) 
'n_estimators' number of iterations 448-625 (574) 421-627 (572) 
'min_child_samples' minimum number of samples  
in one leaf 
153-318 (298) 36-111 (55) 
'max_bin' number of feature bins 355-373 (365) 345-398 (372) 
 
We integrated a robust evaluation approach that validates the model performance and ensures 
the model transferability to new data with a hyperparameter tuning component to identify 
suitable setting for hyperparameters governing the model performance. 
Nested cross validation has been proposed to give the lower generalization error and less 
degradation in model performance by overcoming the bias and overfitting compared to single 
loop cross validation.32 Here we observed comparable model performance of the investigated 
algorithms on the internal validation and the external test sets for the individual datasets (Figure 
2 and 3) and also on average (Figure 4). This was true for models built using molecular 
descriptors and fingerprints as well. The comparable model performance on both validation 
and test sets indicates that the applied nested cross validation strategy offers generalizability 
and transferability of the developed model to previously unseen new data. In order to obtain 
the best performance from each investigated algorithm, we performed hyperparameter 
optimization to select the best hyperparameter settings for the modeling tasks at hand. This was 
performed using 100 iterations of Bayesian optimization with Gaussian process as the surrogate 
model and expected improvement acquisition functions23, identifying the settings which 
yielded the best predictive balanced accuracies on the inner validation data. The model 
performance under the same settings were then assessed using outer test data as well. This 
evaluation strategy has the following advantages: 
1) Bayesian optimization method allows faster and more robust hyperparameters 
optimization, comparing to grid search and random search, as the method keeps track of past 
evaluations that are used to form a probabilistic model mapping hyperparameters to a 
probability of the balanced accuracy scoring function.43 
2) In the 10-fold nested cross validation, the input dataset was split into training sets that 
were used to select the ‘best’ hyperparameter settings giving the ‘highest’ balanced accuracies 
on the inner validation data. Model performance under the same hyperparameter settings was 
assessed using outer loop test data. The Bayesian optimization integrated nested cross 
validation scheme incorporating the rapid hyperparameter tuning and robust evaluation 
features allowing us to select the hyperparameter set that resulted in the lowest generalization 
error and prevented the common risk of over-optimizing the algorithm hyperparameters for the 
internal test data, resulting in overestimation of performance on new independent data. 
When evaluating the results from this study, it is important to be aware that cytotoxicity has 
been detected in the Tox21 screening assays. Approximately 6-8% of the testing compounds 
were affected by the cytotoxicity and potentially incorrectly labeled as positives (false 
positives).44,45 The presence of the mislabeled false positives in the activity results might 
mislead the modeling algorithms causing misprediction of negative compounds to positives 
and increase false positive rate as well as reduce sensitivity in the prediction results. 
Conclusions 
In this study, we evaluated the emerging LightGBM classification algorithm using a model 
evaluation and selection scheme incorporating Bayesian optimization and nested 10-fold cross 
validations. The scheme allows rapid hyperparameter tuning and robust assessment of model 
evaluation and transferability. When applying this scheme to compare the predictive power of 
ML algorithms using Tox21 and mutagenicity datasets, LightGBM offered the best 
performance in terms of balanced accuracy for both internal validation and external test sets, 
compared to four widely used algorithms, DNN, RF, SVC, and XGBoost. In addition to the 
excellent predictive performance, LightGBM is also faster and more scalable in model 
development. This is especially apparent when using high dimensional data matrices such as 
fingerprint features. In conclusion, LightGBM is a more effective and scalable ML algorithm 
that is able to fulfill the ever-growing demand for rapid in silico toxicological assessment of 
emerging industrial or pharmaceutical compounds. 
 
Supporting Information 
Equations for calculating performance metrics, tabulated metrics results including balanced 
accuracy, Cohen's kappa, Matthews correlation coefficient, positive predictive values, negative 
predictive value, ROC- area under curve (AUC), sensitivity and specificity values, computation 
time for each of the Tox21 and mutagenicity dataset using the five ML algorithms, and p-values 
for algorithm comparisons. 
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